Aprea TherapeuticsAPRE
13F holders, Q1 2026 (March 31)22holders
5new positions
6sold out
1famous investor
$0.76avg. 13F price*
At the end of Q1 2026, 22 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, unchanged from Q4 2025. 5 opened new positions and 6 sold out. The largest holders were AIGH Capital Management LLC ($775K), Vestal Point Capital, LP ($267K) and Sphera Funds Management LTD. ($206K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $352K |
| Exits | 6 | $500K |
All 13F filers, Q4 2025 → Q1 2026: 1,197,566 shares bought and 648,768 shares sold, net +548,798 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| AIGH Capital Management LLC | 0.16% | Add +174.1% | 1,015,541 | $775K |
| Vestal Point Capital, LP | 0.01% | New | 350,000 | $267K |
| Sphera Funds Management LTD. | 0.04% | No change | 270,000 | $206K |
| Nantahala Capital Management, LLC | 0.01% | No change | 205,760 | $157K |
| Geode Capital Management, LLC | 0.00% | Add +190.9% | 119,131 | $91K |
| Scientech Research LLC | 0.04% | New | 60,281 | $46K |
| BNP Paribas Financial Markets | 0.00% | Add +45.7% | 39,817 | $30K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 38,464 | $29K |
| Renaissance Technologies | 0.00% | New | 25,100 | $19K |
| Morgan Stanley | 0.00% | Reduce -71.0% | 22,330 | $17K |
| LPL Financial LLC | 0.00% | Reduce -19.2% | 21,052 | $16K |
| Vanguard Capital Management LLC | 0.00% | — | 19,622 | $15K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $11K |
| Two Sigma Securities, LLC | 0.00% | New | 13,500 | $10K |
| Susquehanna International Group, LLP | 0.00% | New | 13,018 | $10K |
| BlackRock, Inc. | 0.00% | No change | 8,504 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -34.5% | 5,127 | $4K |
| UBS Group AG | 0.00% | Reduce -12.5% | 2,153 | $2K |
| Group One Trading LLC | 0.00% | No change | 577 | $440 |
| Osaic Holdings, Inc. | 0.00% | Reduce -1.7% | 295 | $225 |
| WealthCollab, LLC | 0.00% | No change | 158 | $121 |
| SBI Securities Co., Ltd. | 0.00% | Add +6.7% | 16 | $12 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.